Abstract Title:

Inhibition of urinary bladder cancer cell proliferation by silibinin.

Abstract Source:

Environ Mol Mutagen. 2020 Feb 20. Epub 2020 Feb 20. PMID: 32078183

Abstract Author(s):

Tatiane Martins Barcelos Barros, Ana Paula Braga Lima, Tamires Cunha Almeida, Glenda Nicioli da Silva

Article Affiliation:

Tatiane Martins Barcelos Barros


Silibinin, a natural compound extracted from milk thistle, has demonstrated antitumor properties in urinary bladder cancer cells; however the role of TP53 gene in these effects is unclear. In order to better understand the molecular and antiproliferative mechanisms of this compound, urinary bladder cancer cells with different TP53 gene status, RT4 (low grade tumor, wild TP53 gene), 5,637 (high grade tumor, grade 2, mutated TP53 gene) and T24 (high grade tumor, grade 3, mutated TP53 gene), were treated with several concentrations of silibinin (1; 5; 10; 50; 100 and 150 μM). Cytotoxicity, pro-oxidant effect, morphological changes, cell migration, cell cycle progression, global methylation profile and relative expression of HOXB3, c-MYC, PLK1, SMAD4, SRC, HAT, HDAC and RASSF1A genes were evaluated. The silibinin presented cytotoxic and pro-oxidant effects in thethree cell lines. In mutated TP53 cells, significant interference in cell migration and cell cycle arrest at the G2/M phase was observed. Additionally, silibinin induced global DNA hypomethylation in the highest grade tumor cells. For wild-type TP53 cells, a sub-G1 apoptotic population was present.Furthermore, there was modulation of gene expression responsible for cell growth (SMAD and c-MYC), migration (SRC), cell cycle kinetics (PLK1), angiogenesis (HOXB3) and of genes associated with epigenetic events such as DNA acetylation (HAT) and deacetylation (HDAC). In conclusion, the silibinin inhibited the urinary bladder tumor cell proliferation independently of TP53 status; however cell cycle effects, gene expression changes and alteration of cell migration are dependent on TP53 status. This article is protected by copyright. All rights reserved.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.